Summit Therapeutics Inc vs Under Armour Inc Class A — how do they compare? Summit Therapeutics Inc trades at $14.57 (market cap $10.48B), while Under Armour Inc Class A trades at $7.3 (market cap $3.07B). The key difference: Summit Therapeutics Inc is far larger — about 3.4× Under Armour Inc Class A's market cap, and Under Armour Inc Class A is trading nearer its 52-week high, Summit Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| SMMT | UAA | |
|---|---|---|
Market Cap | $10.48B | $3.07B |
Sector | Health | Consumer Cyclical |
52-Week High | $29.32 | $8.14 |
52-Week Low | $13.05 | $4.17 |
Enterprise Value | $9.90B | $4.70B |
Trailing returns across standard periods
Latest headlines on both assets
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →Under Armour develops, markets, and distributes athletic apparel, footwear, and accessories in North America and other territories. Consumers of its apparel include professional and amateur athletes, sponsored college and professional teams, and people with active lifestyles. The company sells merchandise through direct-to-consumer, including e-commerce and more than 400 combined factory house and brand house stores, and wholesale channels. Under Armour also operates a digital fitness app called MapMyFitness. The Baltimore-based company was founded in 1996.
Read more on UAA →